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ABSTRACT: As the application of mass spectrometry intensiﬁes
in scope and diversity, the need for advanced instrumentation
addressing a wide variety of analytical needs also increases. To this
end, many modern, top-end mass spectrometers are designed or
modiﬁed to include a wider range of fragmentation technologies,
for example, ECD, ETD, EThcD, and UVPD. Still, the majority of
instrument platforms are limited to more conventional methods,
such as CID and HCD. While these latter methods have
performed well, the less conventional fragmentation methods
have been shown to lead to increased information in many
applications including middle-down proteomics, top-down
proteomics, glycoproteomics, and disulﬁde bond mapping. We
describe the modiﬁcation of the popular Q Exactive Orbitrap mass spectrometer to extend its fragmentation capabilities to
include ECD. We show that this modiﬁcation allows ≥85% matched ion intensity to originate from ECD fragment ion types as
well as provides high sequence coverage (≥60%) of intact proteins and high fragment identiﬁcation rates with ∼70% of ion
signals matched. Finally, the ECD implementation promotes selective disulﬁde bond dissociation, facilitating the identiﬁcation
of disulﬁde-linked peptide conjugates. Collectively, this modiﬁcation extends the capabilities of the Q Exactive Orbitrap mass
spectrometer to a range of new applications.
KEYWORDS: electron capture dissociation, middle-down, top-down, bottom-up, Orbitrap, Q Exactive, disulﬁde, protein,
mass spectrometry, post-translational modiﬁcations
■ INTRODUCTION
The identity, abundance, structure, and degree of modiﬁcation
of proteins within a cell regulate the biological processes that
occur. Because of the importance of understanding these
protein characteristics, the ﬁeld of proteomics aims to analyze
the entirety of the proteoforms present within a system. Mass
spectrometry (MS) has evolved to become a key analytical
technique in the ﬁeld of proteomics owing to its sensitivity,
speed, and selectivity.1 In a standard MS proteomics
experiment, the proteome of interest is isolated, digested by
an enzyme, typically trypsin, and then the resulting peptides
are separated with liquid chromatography (LC), fragmented,
and mass-analyzed with tandem MS (MS/MS) using colli-
sional activation. Then, the protein of origin is identiﬁed
through database searching, matching experimental with
theoretical fragmentation spectra.2,3 Collectively, this workﬂow
is termed bottom-up proteomics. While bottom-up proteomics
excels in identifying proteins, it also has limitations.
Information about post-translational modiﬁcations (PTMs),
residue point mutations, disulﬁde bond linkages, and protein
microheterogeneity can be easily lost. To address these
challenges, other methodologies have been developed. By
analyzing longer peptide segments, which can be generated by
enzymes other than trypsin, or analyzing intact proteins
through techniques termed middle-down and top-down
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proteomics, respectively, more in-depth information about the
protein’s structure, function, and biological state, particularly
concerning the inﬂuence of multiple PTMs, can be
ascertained.4−7 However, while the separation, fragmentation,
and database searching of tryptic peptides have been
thoroughly optimized, there is still a need to optimize the
workﬂows for these emerging applications.
Bottom-up proteomics has so far relied heavily on the use of
collisional activation, such as collisional-induced dissociation
(CID) and higher-energy collisional induced dissociation
(HCD), as these perform very well for tryptic peptides.
When CID and HCD are applied in middle-down or top-down
proteomic workﬂows, these techniques become limited in
extent of backbone cleavage, termed sequence coverage, and
PTM retention, hampering the identiﬁcation and localization
of modiﬁcations and mutations.8,9 To improve upon these
issues, alternative fragmentation methods have been devel-
oped.10−12 Of note are electron-based fragmentation methods,
for example, electron-capture dissociation (ECD) and
electron-transfer dissociation (ETD).
ECD operates by passing a multiply charged precursor ion
through a conﬁned low-energy electron beam. As the precursor
ion moves through this beam, an electron capture event can
occur, giving rise to charge reduction and subsequent covalent
bond cleavage. The predominant bonds cleaved are the
backbone N−Cα bond, yielding c and z ions, with the
exception of N-terminal proline cleavage, due to the proline’s
cyclic nature.10,13,14 Unlike CID, the backbone fragmentation
process is more stochastic, giving rise to higher sequence
coverage.15 In addition to these protein backbone cleavages,
ECD has been demonstrated to preferentially cleave disulﬁde
bonds.16 Disulﬁde bonds present an analytical challenge both
in top-down proteomics and in mapping of the disulﬁde bonds,
as CID and HCD do not cleave the disulﬁde bond without
special functionalization of the disulﬁde bond,17 thus
hampering the fragmentation and identiﬁcation of the linked
conjugated proteins/peptides. Collectively, these attributes of
ECD make it advantageous for inclusion in instrument
platforms to extend the instrument’s capabilities.
For some time, ECD has been available on FT-ICR
instruments.18 Additionally, in recent years two new
approaches on hybrid Q-ToF instruments as well as ECD
implementations on ion trap instruments have been
reported.19−22 Furthermore, an electromagnetostatic cell,
which uses a magnetic ﬁeld to conﬁne low-energy electrons
in a ﬂight path of the analyte ion, facilitating ECD
fragmentation without the need for long reaction times or
ultrahigh vacuum has been reported.23−26 Herein, we describe
a novel modiﬁcation of one of the most widely used proteomic
instrument platforms, the Q Exactive Orbitrap mass
spectrometer, to enable ECD fragmentation through the use
of a newly designed electromagnetostatic ECD cell, utilizing a
double-pass design to increase fragmentation eﬃciency and
sequence coverage of analyte ions, while also allowing for a
combination of ECD and HCD. We use standard peptides and
proteins to demonstrate successful ECD fragmentation, with
data showing high sequence coverage for peptides and proteins
and ≥85% of matched fragments coming from c/z-type
fragment ions as well as the applicability of the modiﬁcation
to a range of applications including top-down identiﬁcation
and disulﬁde bond mapping.
■ INSTRUMENTATION AND METHODS
ECD Cell: Design and Principles of Operation
The cell, shown in Figure 1, is housed in an aluminum sleeve
that ﬁts on the front end of the HCD-cell and connects to the
exit lens from the C-trap. Internally the ECD cell is composed
of seven electrostatic lenses (E1 through E7) with an internal
diameter of 3.0 mm. The width of each electrode is listed in
Supplemental Table 1. E4 houses the ﬁlament, a single loop of
W4 rhenium wire (Scientiﬁc Instrument Services, Ringoes,
NJ), which is heated through variable current regulation and is
biased with an independent electrostatic potential. Two
samarium−cobalt (Sm2Co17) ring magnets, which are
magnetized through the thickness of the ring and have an
operational temperature of up to 350 °C (Grade SM2435,
Chino Magnetism, Fairﬁeld, NJ), are on either side of E4 with
opposing polarities facing each other to establish a “bottle”
conﬁguration of the magnetic ﬁeld (Supplemental Figure 1).
During ECD operation, the ﬁlament current is increased to
start the emission of electrons from the ﬁlament surface. The
magnetic ﬁeld conﬁnes these free electrons in the radial
dimension, while a potential barrier that is applied to both E1
and E6 conﬁnes the electrons in the axial dimension. ECD
occurs when a precursor ion is moved through this conﬁned
electron beam (ca. electron energy <1 eV).
It is of interest to consider the choice to implement ECD
over ETD, which has been developed on many commercial
and research instrument platforms. ECD and ETD result in
similar fragmentation patterns and oﬀer many similar analytical
advantages; however, the implementations of the two
techniques are diﬀerent. With ECD, as described above, a
precursor cation captures an electron to initiate the ﬁrst steps
of fragmentation; however, the use of electrons does not allow
for trapping of the cation and electron together, and thus the
overlap between cations and electrons is often very short,
leading to low fragmentation eﬃciencies. In contrast, ETD uses
an anionic transfer reagent, often a small molecule such as
ﬂuoranthene, which can be trapped concurrently with the
precursor cation, allowing for better overlap between the two
species. To perform ETD, the instrument must include an ion
trap capable of trapping both cations and anions simulta-
neously, as shown by the implementation of ETD on several
linear ion trap orbitrap mass spectrometers. Here we aimed to
increase the fragmentation capabilities of the Q Exactive mass
Figure 1. Schematic of the ECD cell attached to the front of the
HCD-cell. The ECD cell consists of seven electrostatic electrodes and
two ring magents. Electrons are generated by a heated rhenium
ﬁlament at the center of the cell.
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spectrometer through the least invasive means possible in a
way that can be implemented without needing to access
proprietary internal programming of commercial instrument
platforms. Owing to the base hardware design of the Q
Exactive Orbitrap mass spectrometer, implementation of ETD
would require major modiﬁcation to the ion timing workﬂow
coding within the embedded PC of the instrument and major
modiﬁcations to hardware design itself: Both of which would
preclude the majority of researchers from being able to
implement such modiﬁcations on their own machine and
workﬂows. Instead, the design of the ECD cell described
herein does not require major hardware modiﬁcations and can
operate autonomously from the internal programming of the
mass spectrometer. Moreover, because of the similarity in
analytical metrics of the two fragmentation techniques, the
inclusion of ECD is more amenable to and will have a greater
impact on this instrument platform.
Figure 2. ECD and EChcD spectra of substance P. The ECD (a) spectrum shows ≥90% fragment intensity from c/z ion types. EChcD (b)
fragmentation shows a combination of both b/y and c/z ion types. Insets show the fragment ion intensity percentage. Annotations are predominate
b, c, y, and z ions. b/y ions are shown as blue brackets and c/z ions are shown as red brackets. Typical peptide fragmentation spectra are obtainable
in <30 s of data acquisition.
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Sample Preparation, Data Acquisition, and Data Analysis
Solutions of substance P (SP), myoglobin, and ubiquitin
(Sigma-Aldrich, Zwijndrecht, Netherlands) were prepared to
concentrations of 2 μM using 99.9% water and 0.1% formic
acid. Aliquots of each solution were loaded into a gold-coated
glass capillary emitter and biased +1.2 to 1.35 kV with respect
to heated inlet of the mass spectrometer. ECD fragmentation
mass spectra were collected on a Q Exactive Orbitrap mass
spectrometer modiﬁed with the inclusion of an ECD cell. The
terminal electrode of the ECD cell was electrically coupled to
the C-trap exit lens. The electrostatic potentials applied to
other lenses as well as the current applied to the ﬁlament were
manually tuned to optimize transmission and fragmentation
eﬃciency. The ﬁlaments used were an uncoated rhenium wire
(ECD of SP) or one coated with yttrium oxide (ECD of intact
proteins). Mass spectra of intact proteins were collected with
50 μscans at 140 000 mass resolution and an ion injection time
of 100 ms. Mass spectra of peptides were collected with 10
μscans at 35 000 mass resolution and an ion injection time of
50 ms. A typical peptide fragmentation spectra is obtainable in
<30 s, while protein ECD spectra typically require longer (∼1
min) acquisitions to obtain good signal-to-noise fragmentation
spectra. The injection energy into the HCD-cell was tuned to
minimize collisional activation during ECD-only fragmentation
and set to 25 normalized collision energy (NCE) during ECD-
HCD fragmentation. Methods for ECD of phosphorylated
peptides are presented in the Supporting Information. For
HCD fragmentation of ubiquitin and myoglobin, the instru-
ment was unmodiﬁed; that is, the ECD cell modiﬁcation was
removed, and the NCE was scanned from 15 to 25. To address
the speciﬁcity of ECD toward disulﬁde bond dissociation, a
nonreduced tryptic digest of human serum albumin (HSA)
(Sigma-Aldrich, Zwijndrecht, Netherlands) was prepared to
generate disulﬁde-linked peptide species and analyzed with
LC−MS/MS. The ECD spectra were collected with 5 μscans
at 17 500 mass resolution. Further details regarding the
method of digestion and LC−MS/MS workﬂow can be
found in the Supporting Information.
For tandem spectra of SP, fragments were manually analyzed
for b, c, y, and z ion types. For intact protein analyses, extracted
mass spectra were deconvoluted using Auto Xtract in Protein
Deconvolution 4.0 (Thermo Fisher Scientiﬁc, Bremen,
Germany). Deconvolution settings were S/N Threshold: 1,
Fit Factor: 80%, and Remainder Threshold: 25%. Deconvo-
luted results were searched using ProSight Lite.27 Ion types
matched were b, y, c, and z with a 10 ppm mass error limit.
■ RESULTS AND DISCUSSION
Performance and Advantages of ECD Cell Design
The ECD fragmentation spectrum of SP [M + 2H]2+ ion
(Figure 2a) demonstrates the advantages of the design of the
modiﬁcation. The spectrum consists of a full range of c ions,
with only the prohibited N-terminal proline cleavages missing,
and one z ion, conﬁrming that the ECD cell is well functioning
and capable of selective ECD fragmentation (matched
fragments are listed in Supplemental Table 2). Of interest is
the charge state of the precursor. While both ECD and ETD
have demonstrated their utility to numerous applications in the
proteomic ﬁeld, one inherent limitation is the charge-state
dependence; that is, as the charge state is reduced, the
fragmentation eﬃciency also reduces.28 Thus [M+2H]2+ ions
present a challenging case for electron fragmentation methods;
however, the ECD cell design takes steps to address this
limitation. The placement of the device between the HCD-cell
and the C-trap allows for analytes to undergo two ECD
fragmentation events, one upon going into the HCD-cell from
the C-trap and the second when being ejected from the HCD-
cell for mass analysis. Thus even for the lowest observed charge
state of SP, the ECD fragmentation spectrum produces 80%
sequence coverage with >90% of the matched ion intensity
arising from ECD type fragment ions (Figure 2a, inset).
Moreover, ECD analysis of phosphorylated peptide ions
demonstrates that the device is capable of maintaining the
labile modiﬁcation and provides site localization information
(Supplemental Figures 2−5).
Figure 3. ECD fragmentation spectra of ubiquitin [M+8H]8+ (a) and Myoglobin [M+20H]20+ (b). Below each spectrum are the corresponding
deconvoluted matched fragment ions, as obtained from Prosight Lite. Red brackets are matched c/z ions, while blue brackets are matched b/y ions.
Data acquisition was performed for ∼1 min.
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Other approaches to increase fragmentation eﬃciency
include the use of supplemental activation. Of note, Frese et
al. created a hybrid technique termed EThcD whereby the ion
of interest is ﬁrst subject to ETD fragmentation and then the
remaining precursor is fragmented with HCD, allowing for the
beneﬁts of both techniques to be present in the resulting
fragmentation spectrum.29 Analogous to this, the ECD cell
modiﬁcation can be operated in a dual mode with both ECD
and HCD, newly termed here as EChcD. During EChcD, the
precursor is subjected to the ﬁrst round of ECD fragmentation;
however, the injection energy into the HCD-cell is increased to
a 25 NCE, fragmenting the remaining precursor with HCD
fragmentation. The EChcD fragmentation spectrum for the [M
+2H]2+ precursor of SP is shown in Figure 2b. Similar to
EThcD, the spectrum shows a combination of both ECD and
HCD fragment types (Figure 2b, inset). All of the c ions
present in the ECD spectrum are retained, while there are an
additional nine b ions and two y ions present, giving full
sequence coverage with multiple b/c pairings, termed “golden
pairs”, of the peptide ion. (Matched fragment ions are listed in
Supplemental Table 3.) These data indicate that the ECD cell
adds a high degree of functionality, that is, the ability to do
HCD, ECD, EChcD, to the mass spectrometer and allows for
enhanced workﬂows to be utilized.
Application to Top-Down Proteomics
Fragmentation of longer peptides (middle-down) or intact
proteins (top-down) via HCD or CID is largely hampered by
the selective cleavage of labile bonds that can lead to poor
sequence coverage for peptides or proteins with molecular
weights >10 kDa.9 To address this, the application of electron-
based fragmentation methods, surface-induced dissociation,
and photodissociation have been used, and the modiﬁcation of
commercial instrumentation platforms to include these
fragmentation types is an active ﬁeld of study.9,30 To explore
the utility of the ECD modiﬁcation to the ﬁeld of top-down
proteomics, the analysis of two midsized model proteins,
ubiquitin and myoglobin, was performed.
The ECD fragmentation spectrum of ubiquitin (Figure 3a)
shows a high speciﬁcity for the formation of c/z ion types with
85% of the total fragment composition originating from these
ions (Supplemental Table 4). The same speciﬁcity is shown for
the fragmentation of myoglobin (Figure 3b, Supplemental
Table 5), with 93% fragment composition coming from ECD
fragment types. Furthermore, these ECD spectra exhibit high
sequence coverage, 80 and 60% for ubiquitin and myoglobin,
respectively. To benchmark the ECD fragmentation perform-
ance versus the unmodiﬁed instrument, HCD fragmentation
was performed at a range of NCE values for both protein ions.
HCD of ubiquitin shows that as NCE is increased from 15 to
25 the sequence coverage also increases and reaches a
maximum that is similar to that obtained with ECD (Table
1). For myoglobin, HCD performs substantially worse than
ECD, and the opposite trend is shown with maximal sequence
coverage, 45%, occurring at 15 NCE and dropping to 18% at
25 NCE. These data demonstrate that the ECD modiﬁcation
outperforms the unmodiﬁed instrument for top-down analysis
of myoglobin as well as highlight an apparent limitation of
HCD for top-down proteomic experiments; that is, HCD must
perform well for a wide range of proteins to be eﬀective in
these experiments.
During to- and middle-down experiments, proteins of
varying identity, molecular weight, chemical composition,
and degree of modiﬁcation elute from an LC column and
will be subjected to fragmentation in the mass spectrometer.
To elucidate full information from this experiment, the
fragmentation technique must perform well for a wide range
of proteins. The top-down data show that HCD fragmentation
needs to be optimized for each individual protein; for example,
NCE 15 produces the highest sequence coverage for
myoglobin, while NCE 25 is required for ubiquitin. In
contrast, ECD produces high sequence coverage for both
proteins without optimizing parameters for each individual
analyte and thus will be more amenable to a range of unknown
proteins.
In addition to the need of a versatile fragmentation method,
a successful top-down proteomic experiment also requires the
elucidation of protein identity from a fragmentation mass
spectrum by searching against the full proteome database and
this search returning the correct protein identiﬁcation. To this
end, the quality and percentage of explained fragments present
in the spectrum becomes increasingly important as it limits
search space and reduces the chances of falsely assigning an
unknown protein.31 At 15 NCE, the fragmentation spectrum of
ubiquitin resulted in the highest percentage of matched
fragments with 25%, but as the collision energy increased to
25 NCE, the number of explained fragments decreased to 11%.
Similarly, the fragmentation of myoglobin occurred whereby
an NCE of 15 generated 23% explainable fragments and
decreased to 3% at 25 NCE. In contrast, ECD spectra resulted
in 69% of explained fragments for ubiquitin and 60% for
myoglobin. These data indicate that ECD is a more speciﬁc
fragmentation technique with regard to ion types produced,
which when applied to an unknown protein sample will aid in
correctly identifying the analyte and limit the search space.
Application of ECD for Disulﬁde Mapping
A potential interesting ﬁeld of application of the ECD
modiﬁcation is the use in disulﬁde mapping. Because disulﬁdes
play a critical role in the high-order structure of proteins,
postcolumn, online disulﬁde reduction is gaining a lot of focus
in recent years as it facilitates the identiﬁcation of disulﬁde-
bonded species and their constituting peptides within a protein
sequence.32−34 ECD has previously been shown to dissociate
many disulﬁde bonds more rapidly than any other bonds.16 To
explore this bond speciﬁcity in disulﬁde mapping, the disulﬁde-
bonded species from a nonreduced tryptic digestion of human
serum albumin (HSA) were subjected to ECD fragmentation.
As HSA contains 17 disulﬁde bonds and 8 occurrences of two
Table 1. Collision Energy (NCE), Sequence Coverage, and
Percentage of Explained Fragments for the HCD and ECD
Fragmentation of Ubiquitin and Myoglobin
analyte NCE % sequence coverage % fragments explained
ubiquitin 15 53 25
18 67 23
20 69 20
22 75 14
25 81 11
ECD 80 69
myoglobin 15 45 23
18 48 13
20 43 10
22 28 5
25 18 3
ECD 60 74
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adjacent cysteine residues, proteolytic digestion of HSA will
inherently produce multichain species connected by two or
more disulﬁde bonds. Figure 4 shows two examples of
disulﬁde-linked peptides from HSA, each consisting of three
peptides linked by two disulﬁde bonds. With the ECD
modiﬁcation, selective disulﬁde dissociation was observed, as
the most intense fragment ions were the free disulﬁde-cleaved
peptides (Figure 4). This observation of free reduced peptides
allows for easy identiﬁcation of which peptides constitute the
intact disulﬁde-bonded precursor. In addition to the free
peptides, partially reduced peptide fragments were also
observed in the spectra. These partially reduced species are
the result of selective cleavage of only one of the two disulﬁde
bonds. If a peptide involved in disulﬁde bonding contains more
than a single cysteine residue, for example, T21 and T75
peptides, then these partially reduced species have the
potential to unravel the exact cysteine pairings down to the
residue level by further fragmentation of these species.33
However, depending on the purpose of disulﬁde mapping in
speciﬁc studies, conﬁrmation of expected peptides to be
disulﬁde-bonded after enzymatic digestion is often suﬃcient.
For this, the ECD modiﬁcation on a Q Exactive Orbitrap
shows a promising potential.
■ CONCLUSIONS
An electromagnetostatic ECD cell modiﬁcation was designed
for the benchtop Q Exactive Orbitrap mass spectrometer and
characterized. Data presented herein demonstrate that the
modiﬁcation adds ECD fragmentation capabilities and
produces >85% signal intensity for ECD fragment ion types,
that is, c and z ions, while being able to provide high sequence
coverage for both peptides and proteins. The ECD cell is even
able to produce this high sequence coverage for the [M+2H]2+
ion of SP without the need for supplemental activation owing
to its two-stage ECD fragmentation design. In addition, HCD
functionality of the instrument is maintained and allows for the
combination of ECD with HCD, termed here EChcD,
providing complementary fragmentation information similar
to that of EThcD. The utility to workﬂows such as top-down
proteomics and disulﬁde bond mapping is also demonstrated.
For top-down experiments, the modiﬁcation shows high
speciﬁcity in fragments generated as the number of match
fragments is >60% in ECD as compared with <25% with HCD,
Figure 4. ECD spectra of two disulﬁde linked tripeptide conjugates from a HSA digest. For both, the spectra demonstrate that the disulﬁde bonds
are selectively cleaved and release both free peptides and partially reduced peptide fragments. Numberings are according to an in silico tryptic
digestion of HSA. Data were obtained with single MS scans.
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which will allow for more precise identiﬁcation of unknown
proteins during full proteome experiments.
Finally, selective disulﬁde bond cleavage is shown by the full
and partial reduction of peptides linked through multiple
disulﬁde bonds. The full reduction of these species allows for
the identiﬁcation of linked peptides through their intact mass,
while the partially reduced species could potentially be used to
elucidate the speciﬁc residues linked for peptides containing
more than one cysteine. Collectively, the inclusion of the ECD
cell modiﬁcation expands the utility of the Q Exactive to
workﬂows that were previously unavailable on this platform,
increasing its versatility for modern proteomic research.
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